Frankfurt - Delayed Quote EUR

Poolbeg Pharma PLC (7JN.F)

0.0205
+0.0005
+(2.50%)
At close: May 23 at 8:03:59 AM GMT+2
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
Cost of Revenue
0
0
0
0
Gross Profit
0
0
0
0
Operating Expense
4,686
4,686
4,986
2,336
Operating Income
-4,686
-4,686
-4,986
-2,336
Net Non Operating Interest Income Expense
534
534
209
0
Pretax Income
-4,505
-4,505
-4,777
-2,336
Tax Provision
-574
-574
-91
0
Net Income Common Stockholders
-3,931
-3,931
-4,686
-2,336
Diluted NI Available to Com Stockholders
-3,931
-3,931
-4,686
-2,336
Basic EPS
-0.01
--
-0.01
-0.01
Diluted EPS
-0.01
--
-0.01
-0.01
Basic Average Shares
500,000
--
500,000
317,227.4130
Diluted Average Shares
500,000
--
500,000
317,227.4130
Total Operating Income as Reported
-5,039
-5,039
-4,986
-2,336
Total Expenses
4,686
4,686
4,986
2,336
Net Income from Continuing & Discontinued Operation
-3,931
-3,931
-4,686
-2,336
Normalized Income
-3,622.9771
-3,622.9771
-4,686
-2,336
Interest Income
534
534
209
0
Net Interest Income
534
534
209
0
EBIT
-4,686
-4,686
-4,986
-2,336
EBITDA
-4,660
-4,660
-4,960
-2,318
Reconciled Cost of Revenue
0
0
0
0
Reconciled Depreciation
26
26
26
18
Net Income from Continuing Operation Net Minority Interest
-3,931
-3,931
-4,686
-2,336
Total Unusual Items Excluding Goodwill
-353
-353
0
--
Total Unusual Items
-353
-353
0
--
Normalized EBITDA
-4,307
-4,307
-4,960
-2,318
Tax Rate for Calcs
0.0001
0.0001
0
0
Tax Effect of Unusual Items
-44.9771
-44.9771
0
0
12/31/2021 - 7/23/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

52U.F Hyloris Pharmaceuticals SA
5.84
+5.42%
 
ONTTF Oxford Nanopore Technologies plc
1.6000
0.00%
 
HVO.L hVIVO plc
17.00
+0.59%
 
PXMD PaxMedica, Inc.
0.0001
0.00%
 
RLMD Relmada Therapeutics, Inc.
0.6394
+3.97%
 
ZVRA Zevra Therapeutics, Inc.
8.65
+0.93%
 
CDIO Cardio Diagnostics Holdings, Inc.
3.9500
-6.84%
 
CABA Cabaletta Bio, Inc.
1.7500
-1.69%
 
ATAI Atai Life Sciences N.V.
2.0600
+1.98%
 
REGN Regeneron Pharmaceuticals, Inc.
588.34
-1.43%